Cargando…
RNA and nanocarriers: next generation drug and delivery platform take center stage
The unprecedented rapid deployment of mRNA vaccines against COVID-19 can be traced back to the early studies of RNA nanocarriers, including the study by Zimmermann et al. which showcased the effectiveness of RNA nanocarriers in vivo. This study, among others, ultimately resulted in Onpattro, the fir...
Autor principal: | Rouge, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811353/ https://www.ncbi.nlm.nih.gov/pubmed/36609034 http://dx.doi.org/10.1016/j.tibtech.2022.12.019 |
Ejemplares similares
-
A high-throughput approach of screening nanoparticles for targeted delivery of mRNA
por: Khirallah, Jennifer, et al.
Publicado: (2023) -
Platform trials: the future of medical research?
por: Burki, Talha
Publicado: (2023) -
Clathrin coated pits as signaling platforms for Akt signaling
por: Smythe, Elizabeth
Publicado: (2022) -
Academic specialist education in headache medicine. Next move for the headache community
por: Martelletti, Paolo
Publicado: (2005) -
A TRCky TA protein delivery service snubs the UPS
por: McQuown, Alexander J., et al.
Publicado: (2021)